Nuvalent
Nuvalent is a Massachusetts-based biopharmaceutical company that develops and commercializes small molecule therapies for the treatment of cancer.
Business Model:
Revenue: $0
Employees: 11-50
Industries / Tags:
Detailed Nuvalent Information
Geographic Data
Address: One Broadway
City: Cambridge
State: MA
Zip: 02142
Country: US
Financial Info
Stage:
series b
Raised Last:
$135M
Raised Total:$185M
Social
Metrics
4,652,227Website Global Rank
1,929Website Monthly Traffic
Twitter Followers
Description
Nuvalent is a Massachusetts-based biopharmaceutical company that develops and commercializes small molecule therapies for the treatment of cancer.
Contact Phone:
Contact Email:
Nuvalent went public on 7/28/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/28/2021
IPO Valuation:
$796M
Ticker Symbol:
NUVL
IPO Price:
$17/share
Amount Raised:
$166M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
